Expression of SARS-CoV-2 Nonstructural Proteins 3 and 4 Can Tune the Unfolded Protein Response in Cell Culture.

Autor: Davies JP; Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee 37240, United States., Sivadas A; Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee 37240, United States., Keller KR; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, New York 12310, United States., Roman BK; Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee 37240, United States., Wojcikiewicz RJH; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, New York 12310, United States., Plate L; Department of Biological Sciences, Vanderbilt University, Nashville, Tennessee 37240, United States.; Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37240, United States.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee 37240, United States.

Publikováno v: Journal of proteome research [J Proteome Res] 2024 Jan 05; Vol. 23 (1), pp. 356-367. Date of Electronic Publication: 2023 Dec 01.

SARS-CoV-2 Nonstructural Proteins 3 and 4 tune the Unfolded Protein Response.

Autor: Davies JP; Department of Biological Sciences, Vanderbilt University, Nashville, TN., Sivadas A; Department of Biological Sciences, Vanderbilt University, Nashville, TN., Keller KR; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY., Wojcikiewicz RJH; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY., Plate L; Department of Biological Sciences, Vanderbilt University, Nashville, TN.; Department of Chemistry, Vanderbilt University, Nashville, TN.; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN.

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Jun 12. Date of Electronic Publication: 2023 Jun 12.

Endogenous Bok is stable at the endoplasmic reticulum membrane and does not mediate proteasome inhibitor-induced apoptosis.

Autor: Bonzerato CG; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Keller KR; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Schulman JJ; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Gao X; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Szczesniak LM; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Wojcikiewicz RJH; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Dec 19; Vol. 10, pp. 1094302. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022).

Identification of the Bok Interactome Using Proximity Labeling.

Autor: Szczesniak LM; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Bonzerato CG; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States., Wojcikiewicz RJH; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, United States.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 May 31; Vol. 9, pp. 689951. Date of Electronic Publication: 2021 May 31 (Print Publication: 2021).

Epsin-mediated degradation of IP3R1 fuels atherosclerosis.

Autor: Dong Y; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Lee Y; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Cui K; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., He M; Department of Medicine, University of California, San Diego, San Diego, CA, 92093, USA., Wang B; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Bhattacharjee S; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Zhu B; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Yago T; Cardiovascular Biology Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA., Zhang K; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Deng L; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, 02115, USA., Ouyang K; Department of Medicine, University of California, San Diego, San Diego, CA, 92093, USA., Wen A; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Cowan DB; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Song K; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Yu L; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Brophy ML; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Liu X; Center for Vascular and Developmental Biology, Feinberg Cardiovascular Research Institute, Feinberg School of Medicine, Chicago, IL, 60611, USA., Wylie-Sears J; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Wu H; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Wong S; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Cui G; Department of Nutrition and Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA., Kawashima Y; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA.; Center for Disease Proteomics, Kitasato University School of Science, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan., Matsumoto H; Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA., Kodera Y; Center for Disease Proteomics, Kitasato University School of Science, 1-15-1 Kitasato, Minami-ku, Sagamihara, Kanagawa, 252-0373, Japan., Wojcikiewicz RJH; Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA., Srivastava S; Department of Medicine, Division of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, KY, 40202, USA., Bischoff J; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Wang DZ; Department of Cardiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Ley K; La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA., Chen H; Vascular Biology Program, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA. hong.chen@childrens.harvard.edu.

Publikováno v: Nature communications [Nat Commun] 2020 Aug 07; Vol. 11 (1), pp. 3984. Date of Electronic Publication: 2020 Aug 07.